6-29173702-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_030905.3(OR2J2):āc.67C>Gā(p.Gln23Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000195 in 1,613,446 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_030905.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR2J2 | NM_030905.3 | c.67C>G | p.Gln23Glu | missense_variant | 2/2 | ENST00000641417.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR2J2 | ENST00000641417.1 | c.67C>G | p.Gln23Glu | missense_variant | 2/2 | NM_030905.3 | P1 | ||
OR2J2 | ENST00000377167.3 | c.67C>G | p.Gln23Glu | missense_variant | 1/1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 151958Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000923 AC: 23AN: 249138Hom.: 0 AF XY: 0.0000962 AC XY: 13AN XY: 135178
GnomAD4 exome AF: 0.000204 AC: 298AN: 1461488Hom.: 1 Cov.: 30 AF XY: 0.000220 AC XY: 160AN XY: 727032
GnomAD4 genome AF: 0.000105 AC: 16AN: 151958Hom.: 0 Cov.: 31 AF XY: 0.0000809 AC XY: 6AN XY: 74204
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 21, 2021 | The c.67C>G (p.Q23E) alteration is located in exon 1 (coding exon 1) of the OR2J2 gene. This alteration results from a C to G substitution at nucleotide position 67, causing the glutamine (Q) at amino acid position 23 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at